A Stability-Indicating RP-LC method for the Determination of Related Substances in Simvastatin
A gradient reverse-phase liquid chromatographic (RP-LC)
method was developed for the determination of related substances in Simvastatin
drug substance. Simvastatin is a potent competitive inhibitor of HMG-CoA
reductase, the rate-limiting enzyme in cholesterol biosynthesis, can be used in
treatment of hypercholesterolemia. Good chromatographic separation was achieved
for all the listed known impurities along with some new process impurities from
the peak of interest. The current USP HPLC method for the determination of
related substances of simvastatin is not able to well separate some critical
impurities that may form during the synthetic process or carried over from the
starting materials. The chromatographic separation achieved on a ZORBAX column.
The LC method employs solutions A and B as mobile phase.
Comments
Post a Comment